The team’s entry point was a subtle mutation in histone H3, one of the core protein spools around which DNA is wound. They changed lysine 37, an amino acid predicted to make direct contact with the DNA backbone, into an alanine, creating the H3K37A mutant. The idea was straightforward: if this residue helps grip DNA, removing it should loosen the wrap. That is precisely what happened, but the downstream effects were anything but subtle. Cells carrying H3K37A began degrading their histones, a hallmark of chromatin instability, and their TORC1 kinase went into overdrive. Hyperactive TORC1 is normally a sign of a cell awash in nutrients; here it appeared without any change in the food supply, driven instead by a single altered amino acid in the genome’s packaging material.

To understand whether this TORC1 hyperactivation was merely a side effect or something with real consequences, the researchers threw a pharmacological wrench into the pathway. When they inhibited TORC1 in H3K37A cells, the cells died. This was the study’s first surprise, because TORC1 inhibition is usually survivable, if uncomfortable, for yeast. The toxicity was not a general property of chromatin instability, either. The team compared H3K37A to cells carrying wild-type histone H3 in which chromatin stability had been undermined by other means. Those cells also lost histones and also showed hyperactivated TORC1, yet they tolerated TORC1 inhibition just fine. Something about the H3K37A mutation specifically, rather than loose chromatin per se, primed cells for catastrophe when the nutrient-sensing pathway was throttled back.

The genetic interactions sharpened that conclusion. When the researchers combined H3K37A with mutations that destabilize chromatin in an otherwise wild-type histone context, the defects did not simply add up; they compounded. Histone loss grew worse, TORC1 activity climbed higher, and lethality during TORC1 inhibition became more severe. This synergy suggests that H3K37A and general chromatin instability damage overlapping but distinct aspects of genome packaging, and that the cell can absorb a certain amount of damage from either source alone. Pushed from both directions at once, the buffering capacity collapses. The result is a dose-response relationship between chromatin integrity and TORC1 control that had not been appreciated before, positioning histone-DNA contacts as an upstream restraint on one of the cell’s most consequential signaling pathways.

Why would a wobbly nucleosome care about a nutrient kinase? The answer, according to transcriptome profiling, lies in the mitochondria. The gene expression analysis revealed that H3K37A cells misregulate mitochondrial retrograde signaling, a stress-response program through which dysfunctional mitochondria inform the nucleus and trigger compensatory metabolic rewiring. In yeast, this pathway is classically activated when respiratory function falters, allowing cells to reconfigure carbon metabolism and survive on fermentation. In the mutant, this program was already deregulated at baseline, and inhibiting TORC1 made the derangement dramatically worse. The combination of a strained retrograde response and a suppressed growth pathway proved lethal, indicating that the two systems normally cooperate to keep mitochondrial stress manageable during metabolic adaptation.

The mechanistic thread connecting chromatin to mitochondrial function turned out to be protein import. The researchers found that H3K37A cells were defective in importing at least one oxidative phosphorylation, or OXPHOS, subunit into the mitochondria. OXPHOS complexes are assembled from components made in the cytosol and threaded through mitochondrial membrane transport machinery; a bottleneck at this step starves the respiratory chain of parts and undermines energy production. Defective import of an OXPHOS subunit provides a concrete, testable link between the nuclear defect and the mitochondrial phenotype, explaining how a histone mutation expressed in the nucleus can compromise the electron transport chain embedded in the inner mitochondrial membrane.

Two rescue experiments cemented the causal chain. First, when the team inactivated the retrograde pathway itself, the toxicity of TORC1 inhibition in H3K37A cells was prevented. This may seem paradoxical, since the retrograde response is usually framed as protective, but a misfired or incomplete retrograde program can apparently be worse than none at all, pushing cells into a metabolic configuration incompatible with reduced TORC1 activity. Second, neutralizing reactive oxygen species, the chemically reactive byproducts of mitochondrial electron leakage that accumulate when respiration goes awry, also blocked the lethality. Together, these results sketch a coherent pathway: chromatin instability deregulates retrograde signaling, retrograde dysfunction impairs mitochondrial protein import and respiratory capacity, ROS accumulate, and the cell crosses a viability threshold when TORC1 is simultaneously inhibited.

The conceptual payoff is the demonstration of bidirectional communication between chromatin and TORC1. The canonical view has TORC1 sitting at the top of a signaling hierarchy, phosphorylating downstream effectors that include chromatin-modifying enzymes and transcriptional regulators, thereby imposing nutrient-dependent patterns of gene expression. The new data invert part of that picture. Chromatin stability, embodied in a single histone residue that touches DNA, acts as an input that constrains TORC1 output. Lose that constraint and TORC1 hyperactivates, independent of nutrient status. This reframes chromatin not merely as a passive target of metabolic signaling but as an active participant in metabolic homeostasis, with histone-DNA contacts serving as a structural sensor whose integrity feeds back into growth control.

The study also assigns a previously unknown job to histone H3 lysine 37. Beyond its structural role in the nucleosome, the residue appears to have an additional functionality that protects mitochondrial regulation during metabolic stress adaptation. That kind of dual assignment is becoming a theme in chromatin biology, where histone residues are increasingly recognized as nodes connecting genome architecture to cellular physiology. It also raises evolutionary questions about why a DNA-contacting residue would be conserved partly for its role in mitochondrial governance, and whether analogous histone mutations in other organisms, including human disease variants, produce comparable metabolic vulnerabilities.

For the broader research community, the work opens several practical avenues. Cells with compromised chromatin may be silently hyperactivating TORC1, confounding experiments that interpret TORC1 activity purely as a readout of nutrient availability. Conversely, therapies that inhibit TOR signaling, a strategy under active investigation in cancer and aging research, could carry unappreciated risks for cells with chromatin instability, a common feature of tumors. And the mitochondria-centered toxicity mechanism suggests that antioxidants or interventions targeting retrograde signaling might mitigate such risks in susceptible contexts. What began as a question about a single lysine in a histone tail region has ended as a demonstration that the genome’s packaging material helps guard the cell’s energy supply, and that when the packaging fails, the growth-control machinery and the mitochondria fail with it.

Subject of Research: How chromatin stability regulates TORC1 signaling and mitochondrial homeostasis in yeast

Article Title: Chromatin stability safeguards mitochondrial homeostasis and restrains TORC1 signaling

Article References: Sigamani, V., Yousuf, M., Johnson, D. L., Strahl, B. D., & Laribee, R. N. (2026). Chromatin stability safeguards mitochondrial homeostasis and restrains TORC1 signaling. PLOS Genetics, 22(10), e1012330. https://doi.org/10.1371/journal.pgen.1012330

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012330

Keywords: chromatin, TORC1, histone H3, mitochondria, retrograde signaling, yeast genetics, reactive oxygen species, OXPHOS, nutrient signaling, histone degradation, PLOS Genetics, metabolic stress

The researchers exploited a classic feature of Saccharomyces cerevisiae biology: the ability to separate proliferative growth from long-term survival. When yeast cells exhaust the nutrients in their medium, they stop dividing and enter a stationary phase in which their fate depends on stress adaptation rather than replication. By supplementing cultures with copper sulfate across a twelve-point concentration range from 0 to 200 micromolar, the team found that copper left growth kinetics completely untouched. Yet when they measured survival days later using outgrowth assays, in which aged cells are reinoculated into fresh medium and their regrowth quantified, the difference was dramatic. By day sixteen, untreated cultures retained less than ten percent viability, while copper-supplemented cultures approached one hundred percent survival at concentrations of 6.25 micromolar and above.

Iron told a similar but not identical story. Iron sulfate also preserved stationary-phase viability without affecting growth, and it did so at even lower effective concentrations, maintaining near-complete survival across a range extending down to roughly 0.39 micromolar. The effects were reproduced with chloride salts of both metals, confirming that the counterion was irrelevant. The convergence was striking: two redox-active metals, both essential cofactors for mitochondrial enzymes, both capable of generating damaging free radicals when mishandled, both extending the lifespan of starving cells. But the similarity ended at the phenotype. When the researchers began pulling apart the mechanisms, copper and iron revealed themselves as agents of two fundamentally different survival strategies.

The first clue came from iron chelation. When the team used bathophenanthrolinedisulfonic acid, or BPS, to sequester ferrous iron, cells showed a pronounced growth defect and a sharp downregulation of genes encoding the mitochondrial electron transport chain, spanning complexes I through V, as well as tricarboxylic acid cycle genes. Iron supplementation restored both growth and respiratory gene expression. Critically, copper could only partially rescue the growth defect, and its pro-survival effect proved entirely dependent on iron availability. Even modest chelation with 6.25 micromolar BPS eliminated the survival benefit of low copper doses, and 12.5 micromolar BPS abolished copper’s benefit across all tested concentrations. Copper, in other words, does not act as an independent survival factor; it works through iron-dependent metabolic and redox machinery.

The most surprising result emerged under severe iron limitation. At 25 micromolar BPS, a concentration that drastically slowed proliferation, cells actually survived better in stationary phase without any added metal at all. This iron-starvation-induced survival state, likely reflecting reduced nutrient signaling and a shift toward stress adaptation, was actively disrupted by low-to-moderate copper supplementation, which reduced viability relative to chelation alone. Only higher copper doses retained pro-survival activity under these conditions. The interaction between the two metals is therefore non-linear and state-dependent: copper can support survival, interfere with an alternative survival program, or do nothing, depending on the metabolic configuration of the cell.

To map these configurations onto known signaling pathways, the team turned to the two master regulators of eukaryotic nutrient response: Target of Rapamycin Complex 1, or TORC1, which promotes anabolic growth when nutrients are plentiful, and AMP-activated protein kinase, known as Snf1 in yeast, which orchestrates adaptation to energy and oxidative stress. The divergence between the metals became unmistakable here. Iron-dependent survival required a TORC1-permissive state. Low-dose rapamycin, a TORC1 inhibitor, attenuated iron’s survival benefit, and iron remained incompatible with TORC1 inhibition even at higher drug concentrations. Genetic deletion of GTR1 or EGO1, upstream activators of TORC1, or of SCH9, a major TORC1 effector, similarly diminished iron’s benefit. Biochemical measurements confirmed the mechanism: iron supplementation sustained phosphorylation of Sch9 through the transition into stationary phase, indicating persistent TORC1 activity, whereas untreated cells showed the normal decline.

Copper behaved in nearly the opposite manner. It retained its pro-survival effect under rapamycin treatment, and at higher rapamycin concentrations the two interventions cooperated, enhancing survival beyond either alone. Copper also preserved its benefit in gtr1, ego1, and sch9 deletion strains, and under calorie restriction, a physiological condition that suppresses TORC1, copper supplementation further extended survival while iron supplementation actually blunted the calorie-restriction benefit. Taken together, these results define two viable metabolic configurations for long-term survival: an iron-supported state linked to sustained TORC1 activity and mitochondrial engagement, and a copper-supported state compatible with, and even favored by, TORC1 restriction.

The copper pathway converged on AMPK/Snf1 and antioxidant defense. Copper’s survival benefit was attenuated in snf1 deletion mutants, and its protection against the respiratory chain inhibitor antimycin A was largely Snf1-dependent. Copper also relied on SOD2, the mitochondrial superoxide dismutase: in sod2 mutants, copper’s benefit was diminished and required higher doses for partial rescue, whereas iron robustly restored survival in the same mutants even at low concentrations. Under acute hydrogen peroxide challenge, low copper doses conferred a hormetic, dose-dependent protection that vanished in snf1 cells, while iron provided broader protection that became Snf1-dependent only under severe stress. Measurements of mitochondrial membrane potential added a temporal dimension: iron produced a strong but transient early boost in mitochondrial activity, whereas copper elicited a more moderate and durable response, consistent with maintenance rather than maximal stimulation. Both metals also rescued survival when vacuolar function was disrupted by concanamycin A, suggesting that metal availability can buffer organelle-level dysfunction.

The authors frame these findings as a framework for understanding how micronutrient homeostasis intersects with nutrient sensing during aging. Aging tissues are characterized by declining AMPK activity, dysregulated iron metabolism, and altered TORC1 signaling, and the study suggests that such shifts could change whether copper or iron availability benefits or harms a cell. The implications extend to cancer as well: iron is increasingly targeted therapeutically through ferroptosis-inducing strategies, yet this work shows iron can also support cellular persistence under the nutrient-limited conditions typical of tumor microenvironments. The authors caution that whether these mechanisms are conserved in mammalian cells remains to be determined, and future work in human systems will be needed. But the core message is already clear: the consequences of micronutrient availability are not fixed properties of the metals themselves. They are dynamically shaped by the metabolic and signaling state of the cell, meaning that any intervention aimed at tweaking copper or iron levels, whether for longevity or disease treatment, must first account for the cellular context in which those metals will act.

Subject of Research: Distinct metabolic and nutrient-signaling pathways by which copper and iron regulate cellular survival under nutrient limitation

Article Title: Copper and iron engage distinct metabolic programs for cellular survival

Article References: Naaz, A., Cheng, T. Y. N., Lin, J. J., Gao, M., Dorajoo, R., Kennedy, B. K., & Alfatah, M. (2026). Copper and iron engage distinct metabolic programs for cellular survival. GeroScience. https://doi.org/10.1007/s11357-026-02527-x

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02527-x

Keywords: copper, iron, TORC1, AMPK, mitochondria, cellular survival, nutrient signaling, oxidative stress, chronological lifespan, yeast, aging, micronutrients